Estimates Revisions Lexeo Therapeutics, Inc.
Stocks
LXEO
US52886X1072
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 3.380 USD | -1.17% |
|
-3.98% | -65.96% |
| 09-22 | Lexeo Therapeutics, Inc., Mantle Therapeutics Inc. - M&A Call | |
| 09-22 | Lexeo Therapeutics to Acquire Mantle Therapeutics for Up to $21.3 Million; Enters Three Research Collaborations | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- LXEO Stock
- Consensus Lexeo Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
